LON:CREO Creo Medical Group (CREO) Share Price, News & Analysis GBX 12.50 -0.75 (-5.66%) As of 08/1/2025 12:42 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock About Creo Medical Group Stock (LON:CREO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Creo Medical Group alerts:Sign Up Key Stats Today's Range 12.50▼ 13.2550-Day Range 12.25▼ 16.1352-Week Range 9.22▼ 37Volume321,360 shsAverage Volume1.20 million shsMarket Capitalization£50.53 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. The Company's vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive. The Group has developed the CROMA powered by Kamaptive full-spectrum adaptive technology to optimise surgical capability and patient outcomes. Kamaptive is a seamless, intuitive integration of multi-modal energy sources, optimised to dynamically adapt to patient tissue during procedures such as resection, dissection, coagulation and ablation of tissue. Kamaptive technology provides clinicians with increased flexibility, precision and controlled surgical solutions. CROMA currently delivers bipolar radiofrequency ("RF") energy for precise localised cutting and focused high frequency microwave ("MW") energy for controlled coagulation and ablation via a single accessory port. This technology, combined with the Group's range of patented electrosurgical devices, is designed to provide clinicians with flexible, accurate and controlled clinical solutions. The Directors believe the Company's technology can impact the landscape of surgery and endoscopy by providing a safer, less-invasive and more cost-efficient option for procedures. For more information, please refer to the website www.creomedical.com Read More Receive CREO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Creo Medical Group and its competitors with MarketBeat's FREE daily newsletter. Email Address CREO Stock News HeadlinesCraig Jonathan Gulliford Sells 6,429 Shares of Creo Medical Group PLC (LON:CREO) StockJuly 25, 2025 | insidertrades.comCreo Medical Group PLC (LON:CREO) Insider Craig Jonathan Gulliford Sells 6,429 Shares of StockJuly 25, 2025 | americanbankingnews.comEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to unlock federal lands, oil reserves, and buried minerals... all for profit. Trump's team is already executing the orders... and Wall Street legend Whitney Tilson is stepping forward to show you how to position before the deadline. | Stansberry Research (Ad)Insider Selling: Creo Medical Group PLC (LON:CREO) Insider Sells 6,429 Shares of StockJuly 24, 2025 | americanbankingnews.comCreo Medical hails US reimbursement milestone for Speedboat procedureMay 28, 2025 | lse.co.ukCreo Medical Group Full Year 2024 Earnings: Misses ExpectationsMay 20, 2025 | finance.yahoo.comCreo Medical has "positive outlook", despite widened 2024 lossMay 19, 2025 | lse.co.ukInsider Stock Buying Reaches UK£985.5k On Creo Medical GroupApril 4, 2025 | uk.finance.yahoo.comSee More Headlines CREO Stock Analysis - Frequently Asked Questions How have CREO shares performed this year? Creo Medical Group's stock was trading at GBX 20.40 on January 1st, 2025. Since then, CREO stock has decreased by 38.7% and is now trading at GBX 12.50. How were Creo Medical Group's earnings last quarter? Creo Medical Group PLC (LON:CREO) announced its earnings results on Monday, May, 19th. The company reported ($8.00) earnings per share for the quarter. Creo Medical Group had a negative trailing twelve-month return on equity of 41.79% and a negative net margin of 73.93%. How do I buy shares of Creo Medical Group? Shares of CREO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Creo Medical Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Creo Medical Group investors own include Aviva (AV), IQE (IQE), Lloyds Banking Group (LLOY), Barclays (BARC), BP (BP), BT Group (BT.A) and Coats Group (COA). Company Calendar Last Earnings5/19/2025Today8/01/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolLON:CREO CIKN/A Webcreomedical.com Phone+44-1291-606005FaxN/AEmployees279Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (6.32) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£25.04 million Net Margins-73.93% Pretax MarginN/A Return on Equity-41.79% Return on Assets-20.09% Debt Debt-to-Equity Ratio29.96 Current Ratio3.24 Quick Ratio2.19 Sales & Book Value Annual Sales£33.87 million Price / Sales1.49 Cash FlowGBX 5.14 per share Price / Cash Flow2.43 Book ValueGBX 13.11 per share Price / Book0.95Miscellaneous Outstanding Shares404,265,846Free FloatN/AMarket Cap£50.53 million OptionableNot Optionable Beta0.86 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (LON:CREO) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creo Medical Group PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Creo Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.